A combination of epitope prediction and molecular docking allows for good identification of MHC class I restricted T-cell epitopes

Abstract In silico identification of T-cell epitopes is emerging as a new methodology for the study of epitope-based vaccines against viruses and cancer. In order to improve accuracy of prediction, we designed a novel approach, using epitope prediction methods in combination with molecular docking techniques, to identify MHC class I restricted T-cell epitopes. Analysis of the HIV-1 p24 protein and influenza virus matrix protein revealed that the present approach is effective, yielding prediction accuracy of over 80% with respect to experimental data. Subsequently, we applied such a method for prediction of T-cell epitopes in SARS coronavirus (SARS-CoV) S, N and M proteins. Based on available experimental data, the prediction accuracy is up to 90% for S protein. We suggest the use of epitope prediction methods in combination with 3D structural modelling of peptide-MHC-TCR complex to identify MHC class I restricted T-cell epitopes for use in epitope based vaccines like HIV and human cancers, which should provide a valuable step forward for the design of better vaccines and may provide in depth understanding about activation of T-cell epitopes by MHC binding peptides.

[1]  R Elber,et al.  Knowledge-based structure prediction of MHC class I bound peptides: a study of 23 complexes. , 1998, Folding & design.

[2]  Gajendra P. S. Raghava,et al.  ProPred1: Prediction of Promiscuous MHC Class-I Binding Sites , 2003, Bioinform..

[3]  Weifeng Chen,et al.  T-Cell Epitopes in Severe Acute Respiratory Syndrome (SARS) Coronavirus Spike Protein Elicit a Specific T-Cell Immune Response in Patients Who Recover from SARS , 2004, Journal of Virology.

[4]  Kun Yu,et al.  Methods for Prediction of Peptide Binding to MHC Molecules: A Comparative Study , 2002, Molecular medicine.

[5]  Thomas Lengauer,et al.  Predicting MHC class I epitopes in large datasets , 2010, BMC Bioinformatics.

[6]  O. Schueler‐Furman,et al.  Structure‐based prediction of binding peptides to MHC class I molecules: Application to a broad range of MHC alleles , 2000, Protein science : a publication of the Protein Society.

[7]  K. Holmes.  SARS coronavirus: a new challenge for prevention and therapy. , 2003, The Journal of clinical investigation.

[8]  J. Reidhaar-Olson,et al.  The use of bioinformatics for identifying class II-restricted T-cell epitopes. , 2003, Methods.

[9]  Partho Ghosh,et al.  Structure of the complex between human T-cell receptor, viral peptide and HLA-A2 , 1996, Nature.

[10]  E. Reinherz,et al.  Prediction of MHC class I binding peptides using profile motifs. , 2002, Human immunology.

[11]  Gajendra P.S. Raghava,et al.  Prediction of CTL epitopes using QM, SVM and ANN techniques. , 2004, Vaccine.

[12]  Sneh Lata,et al.  Application of machine learning techniques in predicting MHC binders. , 2007, Methods in molecular biology.

[13]  N. Sato,et al.  Identification of an HLA-A*0201-restricted cytotoxic T lymphocyte epitope from the lung carcinoma antigen, Lengsin. , 2011, International journal of oncology.

[14]  J. Whitton,et al.  A "string-of-beads" vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge , 1993, Journal of virology.

[15]  C. Leclerc,et al.  Delivery of Multiple Epitopes by Recombinant Detoxified Adenylate Cyclase of Bordetella pertussisInduces Protective Antiviral Immunity , 2001, Journal of Virology.

[16]  D. Flower,et al.  Quantitative approaches to computational vaccinology , 2002, Immunology and cell biology.

[17]  Ying-hua Chen,et al.  Epitope-vaccine strategy against HIV-1: today and tomorrow. , 2003, Immunobiology.

[18]  Andrew Connor,et al.  A string of beads. , 2008, The American journal of medicine.

[19]  Ruth Nussinov,et al.  Taking geometry to its edge: Fast unbound rigid (and hinge‐bent) docking , 2003, Proteins.

[20]  Huanghao Yang,et al.  T-Cell Epitopes in Severe Acute Respiratory Syndrome (SARS) Coronavirus Spike Protein Elicit a Specific T-Cell Immune Response in Patients Who Recover from SARS , 2004, Journal of Virology.

[21]  Pingping Guan,et al.  MHCPred: a server for quantitative prediction of peptide-MHC binding , 2003, Nucleic Acids Res..

[22]  Ruifu Yang,et al.  Identification of an HLA-A*0201–restricted CD8+ T-cell epitope SSp-1 of SARS-CoV spike protein , 2004, Blood.

[23]  K. Parker,et al.  Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. , 1994, Journal of immunology.

[24]  John Sidney,et al.  Examining the independent binding assumption for binding of peptide epitopes to MHC-I molecules , 2003, Bioinform..

[25]  S Brunak,et al.  SARS CTL Vaccine Candidates — HLA Supertype, Genome‐Wide Scanning and Biochemical Validation , 2004, Tissue antigens.

[26]  Arne Elofsson,et al.  Prediction of MHC class I binding peptides, using SVMHC , 2002, BMC Bioinformatics.

[27]  Michael A. Gonzalez,et al.  From genome to vaccine: in silico predictions, ex vivo verification. , 2001, Vaccine.

[28]  Morten Nielsen,et al.  Major histocompatibility complex class I binding predictions as a tool in epitope discovery , 2010, Immunology.

[29]  H. Rammensee,et al.  SYFPEITHI: database for MHC ligands and peptide motifs , 1999, Immunogenetics.

[30]  Anne S De Groot,et al.  Bioinformatics tools for identifying class I-restricted epitopes. , 2003, Methods.

[31]  Hongyi Zhou,et al.  A physical reference state unifies the structure‐derived potential of mean force for protein folding and binding , 2004, Proteins.